Ozempic? O comidas nutritivas? 🥑 Nuevo episodio! #garybrecka #yopudetupuedes #nutricion #ozempic

In this interview segment, Gary Brecka discusses the dual nature of GLP-1 based drugs like Ozempic and Mounjaro, emphasizing that while they can be life‑saving for morbidly obese type‑2 diabetics, they have increasingly become vanity drugs. He explains the physiological role of the gut hormone GLP‑1, which is released in response to nutrient‑dense foods and signals satiety, contrasting the satiating effect of whole, nutrient‑rich foods (e.g., avocados) with the lack of satiety from highly processed, low‑nutrient foods like cereal, Skittles, or Oreos. Brecka argues that overconsumption of processed foods drives obesity and poor health outcomes, pointing to countries with whole‑food diets—Singapore, Mediterranean nations, and France—as examples of high life expectancy despite differing macronutrient profiles. He critiques the United States for its heavily processed diet, linking it to a low global life‑expectancy ranking. The overall message urges a shift toward whole‑food nutrition to naturally regulate appetite via GLP‑1 rather than relying on pharmacological interventions.










